Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 594 entries
Sorted by: Best Match Show Resources per page
Correction.

The journal of allergy and clinical immunology. In practice

[No authors listed]
PMID: 30832888
J Allergy Clin Immunol Pract. 2019 Mar;7(3):1096. doi: 10.1016/j.jaip.2019.01.010.

No abstract available.

Cite
Correction. J Allergy Clin Immunol Pract. 2019;7(3):1096doi: 10.1016/j.jaip.2019.01.010.
(2019). Correction. The journal of allergy and clinical immunology. In practice, 7(3), 1096. https://doi.org/10.1016/j.jaip.2019.01.010
"Correction." The journal of allergy and clinical immunology. In practice vol. 7,3 (2019): 1096. doi: https://doi.org/10.1016/j.jaip.2019.01.010
Correction. J Allergy Clin Immunol Pract. 2019 Mar;7(3):1096. doi: 10.1016/j.jaip.2019.01.010. PMID: 30832888.
Copy Download .nbib Format: NLM
AAAAI Work Group Report: Physician Wellness in Allergy and Immunology.

The journal of allergy and clinical immunology. In practice

Bingemann T, Sharma H, Nanda A, Khan DA, Markovics S, Sussman J, Murphy A, Kalman D, Mosnaim G.
PMID: 32067926
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1224-1229. doi: 10.1016/j.jaip.2020.01.023. Epub 2020 Feb 14.

BACKGROUND: Physician health and wellness can be negatively impacted by burnout, which, in turn, can lead to medical errors and early retirement. Burnout issues can start in medical school and progress during residency, fellowship, and throughout a physician's career....

Cite
Bingemann T, Sharma H, Nanda A, et al. AAAAI Work Group Report: Physician Wellness in Allergy and Immunology. J Allergy Clin Immunol Pract. 2020;8(4):1224-1229doi: 10.1016/j.jaip.2020.01.023.
Bingemann, T., Sharma, H., Nanda, A., Khan, D. A., Markovics, S., Sussman, J., Murphy, A., Kalman, D., & Mosnaim, G. (2020). AAAAI Work Group Report: Physician Wellness in Allergy and Immunology. The journal of allergy and clinical immunology. In practice, 8(4), 1224-1229. https://doi.org/10.1016/j.jaip.2020.01.023
Bingemann, Theresa, et al. "AAAAI Work Group Report: Physician Wellness in Allergy and Immunology." The journal of allergy and clinical immunology. In practice vol. 8,4 (2020): 1224-1229. doi: https://doi.org/10.1016/j.jaip.2020.01.023
Bingemann T, Sharma H, Nanda A, Khan DA, Markovics S, Sussman J, Murphy A, Kalman D, Mosnaim G. AAAAI Work Group Report: Physician Wellness in Allergy and Immunology. J Allergy Clin Immunol Pract. 2020 Apr;8(4):1224-1229. doi: 10.1016/j.jaip.2020.01.023. Epub 2020 Feb 14. PMID: 32067926.
Copy Download .nbib Format: NLM
Correction.

The journal of allergy and clinical immunology. In practice

[No authors listed]
PMID: 31076066
J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1708. doi: 10.1016/j.jaip.2019.03.002.

No abstract available.

Cite
Correction. J Allergy Clin Immunol Pract. 2019;7(5):1708doi: 10.1016/j.jaip.2019.03.002.
(2019). Correction. The journal of allergy and clinical immunology. In practice, 7(5), 1708. https://doi.org/10.1016/j.jaip.2019.03.002
"Correction." The journal of allergy and clinical immunology. In practice vol. 7,5 (2019): 1708. doi: https://doi.org/10.1016/j.jaip.2019.03.002
Correction. J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1708. doi: 10.1016/j.jaip.2019.03.002. PMID: 31076066.
Copy Download .nbib Format: NLM
Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications.

Epilepsy currents

Bermeo-Ovalle A.
PMID: 30955419
Epilepsy Curr. 2019 Mar-Apr;19(2):96-98. doi: 10.1177/1535759719835672.

The Frequency and Clinical Features of Hypersensitivity Reactions to Antiepileptic Drugs in Children: A Prospective Study Guvenir H, Dibek Misirlioglu E, Civelek E. J Allergy Clin Immunol Pract. 2018;6(6):2043-2050.BACKGROUND: Antiepileptic drugs (AEDs) can cause hypersensitivity reactions during childhood. Studies...

Cite
Bermeo-Ovalle A. Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications. Epilepsy Curr. 2019;19(2):96-98doi: 10.1177/1535759719835672.
Bermeo-Ovalle, A. (2019). Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications. Epilepsy currents, 19(2), 96-98. https://doi.org/10.1177/1535759719835672
Bermeo-Ovalle, Adriana. "Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications." Epilepsy currents vol. 19,2 (2019): 96-98. doi: https://doi.org/10.1177/1535759719835672
Bermeo-Ovalle A. Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications. Epilepsy Curr. 2019 Mar-Apr;19(2):96-98. doi: 10.1177/1535759719835672. PMID: 30955419; PMCID: PMC6610416.
Copy Download .nbib Format: NLM
Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy.

The journal of allergy and clinical immunology. In practice

Nilsson C, Scurlock AM, Dellon ES, Brostoff JM, Pham T, Ryan R, Brown KR, Adelman DC, Aceves SS.
PMID: 34389504
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4496-4501. doi: 10.1016/j.jaip.2021.07.048. Epub 2021 Aug 11.

No abstract available.

Cite
Nilsson C, Scurlock AM, Dellon ES, et al. Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy. J Allergy Clin Immunol Pract. 2021;9(12):4496-4501doi: 10.1016/j.jaip.2021.07.048.
Nilsson, C., Scurlock, A. M., Dellon, E. S., Brostoff, J. M., Pham, T., Ryan, R., Brown, K. R., Adelman, D. C., & Aceves, S. S. (2021). Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy. The journal of allergy and clinical immunology. In practice, 9(12), 4496-4501. https://doi.org/10.1016/j.jaip.2021.07.048
Nilsson, Caroline, et al. "Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy." The journal of allergy and clinical immunology. In practice vol. 9,12 (2021): 4496-4501. doi: https://doi.org/10.1016/j.jaip.2021.07.048
Nilsson C, Scurlock AM, Dellon ES, Brostoff JM, Pham T, Ryan R, Brown KR, Adelman DC, Aceves SS. Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4496-4501. doi: 10.1016/j.jaip.2021.07.048. Epub 2021 Aug 11. PMID: 34389504.
Copy Download .nbib Format: NLM
Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial.

The journal of allergy and clinical immunology. In practice

Dunn Galvin A, Lloyd M, Hsiao KC, Tang MLK.
PMID: 34389505
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4493-4495.e1. doi: 10.1016/j.jaip.2021.07.047. Epub 2021 Aug 11.

No abstract available.

Cite
Dunn Galvin A, Lloyd M, Hsiao KC, et al. Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial. J Allergy Clin Immunol Pract. 2021;9(12):4493-4495.e1doi: 10.1016/j.jaip.2021.07.047.
Dunn Galvin, A., Lloyd, M., Hsiao, K. C., Tang, M. L. K. (2021). Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial. The journal of allergy and clinical immunology. In practice, 9(12), 4493-4495.e1. https://doi.org/10.1016/j.jaip.2021.07.047
Dunn Galvin, Audrey, et al. "Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial." The journal of allergy and clinical immunology. In practice vol. 9,12 (2021): 4493-4495.e1. doi: https://doi.org/10.1016/j.jaip.2021.07.047
Dunn Galvin A, Lloyd M, Hsiao KC, Tang MLK. Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4493-4495.e1. doi: 10.1016/j.jaip.2021.07.047. Epub 2021 Aug 11. PMID: 34389505.
Copy Download .nbib Format: NLM
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study.

The journal of allergy and clinical immunology. In practice

Gleich GJ, Roufosse F, Chupp G, Faguer S, Walz B, Reiter A, Yancey SW, Bentley JH, Steinfeld J.
PMID: 34389506
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4431-4440.e1. doi: 10.1016/j.jaip.2021.07.050. Epub 2021 Aug 10.

BACKGROUND: A double-blind, placebo-controlled, phase III study (200622) showed that mepolizumab reduces disease flares for patients with uncontrolled FIP1-like-1-platelet-derived growth factor receptor α-negative hypereosinophilic syndrome (HES) and two or more flares in the previous year.OBJECTIVE: To further characterize the...

Cite
Gleich GJ, Roufosse F, Chupp G, et al. Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study. J Allergy Clin Immunol Pract. 2021;9(12):4431-4440.e1doi: 10.1016/j.jaip.2021.07.050.
Gleich, G. J., Roufosse, F., Chupp, G., Faguer, S., Walz, B., Reiter, A., Yancey, S. W., Bentley, J. H., Steinfeld, J. (2021). Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study. The journal of allergy and clinical immunology. In practice, 9(12), 4431-4440.e1. https://doi.org/10.1016/j.jaip.2021.07.050
Gleich, Gerald J, et al. "Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study." The journal of allergy and clinical immunology. In practice vol. 9,12 (2021): 4431-4440.e1. doi: https://doi.org/10.1016/j.jaip.2021.07.050
Gleich GJ, Roufosse F, Chupp G, Faguer S, Walz B, Reiter A, Yancey SW, Bentley JH, Steinfeld J. Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4431-4440.e1. doi: 10.1016/j.jaip.2021.07.050. Epub 2021 Aug 10. PMID: 34389506.
Copy Download .nbib Format: NLM
Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19.

The journal of allergy and clinical immunology. In practice

Qeadan F, Chehade M, Tingey B, Egbert J, Dellon ES, Peterson KA.
PMID: 34563741
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4473-4476.e4. doi: 10.1016/j.jaip.2021.09.022. Epub 2021 Sep 23.

No abstract available.

Cite
Qeadan F, Chehade M, Tingey B, et al. Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19. J Allergy Clin Immunol Pract. 2021;9(12):4473-4476.e4doi: 10.1016/j.jaip.2021.09.022.
Qeadan, F., Chehade, M., Tingey, B., Egbert, J., Dellon, E. S., & Peterson, K. A. (2021). Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19. The journal of allergy and clinical immunology. In practice, 9(12), 4473-4476.e4. https://doi.org/10.1016/j.jaip.2021.09.022
Qeadan, Fares, et al. "Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19." The journal of allergy and clinical immunology. In practice vol. 9,12 (2021): 4473-4476.e4. doi: https://doi.org/10.1016/j.jaip.2021.09.022
Qeadan F, Chehade M, Tingey B, Egbert J, Dellon ES, Peterson KA. Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4473-4476.e4. doi: 10.1016/j.jaip.2021.09.022. Epub 2021 Sep 23. PMID: 34563741; PMCID: PMC8459462.
Copy Download .nbib Format: NLM
Atopic Eczema-Associated Fracture Risk and Oral Corticosteroids: A Population-Based Cohort Study.

The journal of allergy and clinical immunology. In practice

Matthewman J, Mansfield KE, Prieto-Alhambra D, Mulick AR, Smeeth L, Lowe KE, Silverwood RJ, Langan SM.
PMID: 34571200
J Allergy Clin Immunol Pract. 2022 Jan;10(1):257-266.e8. doi: 10.1016/j.jaip.2021.09.026. Epub 2021 Sep 24.

BACKGROUND: Evidence suggests adults with atopic eczema have increased fracture risk. However, it is unclear whether oral corticosteroids explain the association.OBJECTIVE: To assess to what extent oral corticosteroids mediate the relationship between atopic eczema and fractures.METHODS: We conducted a...

Cite
Matthewman J, Mansfield KE, Prieto-Alhambra D, et al. Atopic Eczema-Associated Fracture Risk and Oral Corticosteroids: A Population-Based Cohort Study. J Allergy Clin Immunol Pract. 2021;10(1):257-266.e8doi: 10.1016/j.jaip.2021.09.026.
Matthewman, J., Mansfield, K. E., Prieto-Alhambra, D., Mulick, A. R., Smeeth, L., Lowe, K. E., Silverwood, R. J., & Langan, S. M. (2022). Atopic Eczema-Associated Fracture Risk and Oral Corticosteroids: A Population-Based Cohort Study. The journal of allergy and clinical immunology. In practice, 10(1), 257-266.e8. https://doi.org/10.1016/j.jaip.2021.09.026
Matthewman, Julian, et al. "Atopic Eczema-Associated Fracture Risk and Oral Corticosteroids: A Population-Based Cohort Study." The journal of allergy and clinical immunology. In practice vol. 10,1 (2022): 257-266.e8. doi: https://doi.org/10.1016/j.jaip.2021.09.026
Matthewman J, Mansfield KE, Prieto-Alhambra D, Mulick AR, Smeeth L, Lowe KE, Silverwood RJ, Langan SM. Atopic Eczema-Associated Fracture Risk and Oral Corticosteroids: A Population-Based Cohort Study. J Allergy Clin Immunol Pract. 2022 Jan;10(1):257-266.e8. doi: 10.1016/j.jaip.2021.09.026. Epub 2021 Sep 24. PMID: 34571200; PMCID: PMC7612204.
Copy Download .nbib Format: NLM
Pattern and impact of drug-induced liver injury in South African patients with Stevens-Johnson syndrome/toxic epidermal necrolysis and a high burden of HIV.

The journal of allergy and clinical immunology. In practice

Nalitye Haitembu BN, Porter MN, Basera W, Hickmann R, Dlamini SK, Spearman CW, Peter JG, Lehloenya RJ.
PMID: 34384931
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4483-4485.e1. doi: 10.1016/j.jaip.2021.07.051. Epub 2021 Aug 09.

No abstract available.

Cite
Nalitye Haitembu BN, Porter MN, Basera W, et al. Pattern and impact of drug-induced liver injury in South African patients with Stevens-Johnson syndrome/toxic epidermal necrolysis and a high burden of HIV. J Allergy Clin Immunol Pract. 2021;9(12):4483-4485.e1doi: 10.1016/j.jaip.2021.07.051.
Nalitye Haitembu, B. N., Porter, M. N., Basera, W., Hickmann, R., Dlamini, S. K., Spearman, C. W., Peter, J. G., & Lehloenya, R. J. (2021). Pattern and impact of drug-induced liver injury in South African patients with Stevens-Johnson syndrome/toxic epidermal necrolysis and a high burden of HIV. The journal of allergy and clinical immunology. In practice, 9(12), 4483-4485.e1. https://doi.org/10.1016/j.jaip.2021.07.051
Nalitye Haitembu, Beata Niita, et al. "Pattern and impact of drug-induced liver injury in South African patients with Stevens-Johnson syndrome/toxic epidermal necrolysis and a high burden of HIV." The journal of allergy and clinical immunology. In practice vol. 9,12 (2021): 4483-4485.e1. doi: https://doi.org/10.1016/j.jaip.2021.07.051
Nalitye Haitembu BN, Porter MN, Basera W, Hickmann R, Dlamini SK, Spearman CW, Peter JG, Lehloenya RJ. Pattern and impact of drug-induced liver injury in South African patients with Stevens-Johnson syndrome/toxic epidermal necrolysis and a high burden of HIV. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4483-4485.e1. doi: 10.1016/j.jaip.2021.07.051. Epub 2021 Aug 09. PMID: 34384931.
Copy Download .nbib Format: NLM
School Asthma Care During COVID-19: What we have learned, and what we are learning.

The journal of allergy and clinical immunology. In practice

Abrams EM, Jordan K, Szefler SJ.
PMID: 34848382
J Allergy Clin Immunol Pract. 2021 Nov 27; doi: 10.1016/j.jaip.2021.11.020. Epub 2021 Nov 27.

The focus of this article is to review school asthma care during COVID-19. Asthma is listed as a risk factor in some guidelines, although children with asthma appear to not be at increased risk of severe respiratory outcomes compared...

Cite
Abrams EM, Jordan K, Szefler SJ. School Asthma Care During COVID-19: What we have learned, and what we are learning. J Allergy Clin Immunol Pract. 2021;doi: 10.1016/j.jaip.2021.11.020.
Abrams, E. M., Jordan, K., & Szefler, S. J. (2021). School Asthma Care During COVID-19: What we have learned, and what we are learning. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.11.020
Abrams, Elissa M, et al. "School Asthma Care During COVID-19: What we have learned, and what we are learning." The journal of allergy and clinical immunology. In practice vol. (2021). doi: https://doi.org/10.1016/j.jaip.2021.11.020
Abrams EM, Jordan K, Szefler SJ. School Asthma Care During COVID-19: What we have learned, and what we are learning. J Allergy Clin Immunol Pract. 2021 Nov 27; doi: 10.1016/j.jaip.2021.11.020. Epub 2021 Nov 27. PMID: 34848382; PMCID: PMC8626345.
Copy Download .nbib Format: NLM
Intimate Partner Violence and Adult Asthma Morbidity: A Population-Based Study.

The journal of allergy and clinical immunology. In practice

Wang E, Simmons B, Holm KE, Alam R, Wamboldt FS.
PMID: 34364825
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4300-4309.e7. doi: 10.1016/j.jaip.2021.06.023. Epub 2021 Aug 04.

BACKGROUND: The etiologies for difficult-to-control asthma are complex and incompletely understood. Intimate partner violence (IPV) is a pervasive problem and may play a role in difficult-to-control asthma. IPV is associated with increased prevalence of asthma. There are no prior...

Cite
Wang E, Simmons B, Holm KE, et al. Intimate Partner Violence and Adult Asthma Morbidity: A Population-Based Study. J Allergy Clin Immunol Pract. 2021;9(12):4300-4309.e7doi: 10.1016/j.jaip.2021.06.023.
Wang, E., Simmons, B., Holm, K. E., Alam, R., & Wamboldt, F. S. (2021). Intimate Partner Violence and Adult Asthma Morbidity: A Population-Based Study. The journal of allergy and clinical immunology. In practice, 9(12), 4300-4309.e7. https://doi.org/10.1016/j.jaip.2021.06.023
Wang, Eileen, et al. "Intimate Partner Violence and Adult Asthma Morbidity: A Population-Based Study." The journal of allergy and clinical immunology. In practice vol. 9,12 (2021): 4300-4309.e7. doi: https://doi.org/10.1016/j.jaip.2021.06.023
Wang E, Simmons B, Holm KE, Alam R, Wamboldt FS. Intimate Partner Violence and Adult Asthma Morbidity: A Population-Based Study. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4300-4309.e7. doi: 10.1016/j.jaip.2021.06.023. Epub 2021 Aug 04. PMID: 34364825.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 594 entries